Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
711 E Lamar Blvd
Ste 200
Arlington, TX 76011Phone+1 817-795-7546Fax+1 817-226-7546
Education & Training
University of Texas Medical Branch HospitalsFellowship, Dermatopathology, 1996 - 1997- University of Texas Medical Branch HospitalsResidency, Dermatology, 1993 - 1996
- University of Texas Medical Branch HospitalsInternship, Internal Medicine, 1992 - 1993
Baylor College of MedicineClass of 1992
Certifications & Licensure
TX State Medical License 1993 - 2025- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Super Doctor SuperDoctors.com
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2010 Aug 01
- Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 Mar 01
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris
JAMA Dermatology. 2024-11-01 - 1 citationsCedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trial.Stephen Tyring, Angela Moore, Akimchi Morita, H Chih-Ho Hong, In-Ho Song
Clinical and Experimental Dermatology. 2024-10-24 - 1 citationsThe Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis.Jennifer Soung, Vivian Laquer, Joseph F Merola, Angela Moore, Hany Elmaraghy
Dermatology and Therapy. 2024-08-01
Press Mentions
Narrow Spectrum Tetracycline for Moderate-to-Severe AcneOctober 11th, 2019
Novel Oral Antibiotic Treatment Seysara™ (Sarecycline) Now AvailableJanuary 17th, 2019
Almirall's Seysara Now AvailableJanuary 17th, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish, Chinese (Mandarin)
External Links
- Arlington Center for Dermatologyhttp://acderm.com/ACD-WP/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
